Simplex Trading, LLC Evaxion Biotech A/S Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$1.12 - $1.74 $7,321 - $11,374	-6,537 Reduced 77.99%	1,845 $2,000
Q1 2023 Apr 27, 2023	BUY	$1.03 - $1.8 $8,633 - $15,087	8,382 New	8,382 $9,000
Q2 2022 Aug 03, 2022	SELL	$1.6 - $3.07 $88 - $168	-55 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$2.66 - $4.65 $917 - $1,604	-345 Reduced 86.25%	55 $0
Q4 2021 Feb 23, 2022	BUY	$4.0 - $12.68 $1,600 - $5,072	400 New	400 $1,000

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $71.2M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.